215380 Stock Chart & Stats
₩2525.00
-₩25.00(-0.98%)
―
--
Day’s Range― - ―
52-Week Range₩1,554.00 - ₩4,535.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)76.89K
Market Cap
₩42.09B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.17
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding16,829,576
10 Day Avg. Volume78,255
30 Day Avg. Volume76,895
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
215380 FAQ
What was WOOJUNG BIO, Inc.’s price range in the past 12 months?
WOOJUNG BIO, Inc. lowest stock price was ₩1554.00 and its highest was ₩4535.00 in the past 12 months.
What is WOOJUNG BIO, Inc.’s market cap?
WOOJUNG BIO, Inc.’s market cap is ₩42.09B.
When is WOOJUNG BIO, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were WOOJUNG BIO, Inc.’s earnings last quarter?
Currently, no data Available
Is WOOJUNG BIO, Inc. overvalued?
According to Wall Street analysts WOOJUNG BIO, Inc.’s price is currently Undervalued.
Does WOOJUNG BIO, Inc. pay dividends?
WOOJUNG BIO, Inc. does not currently pay dividends.
What is WOOJUNG BIO, Inc.’s EPS estimate?
WOOJUNG BIO, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does WOOJUNG BIO, Inc. have?
WOOJUNG BIO, Inc. has 16,829,576 shares outstanding.
What happened to WOOJUNG BIO, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of WOOJUNG BIO, Inc.?
Currently, no hedge funds are holding shares in KR:215380
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
MYUNGMOON Pharm Co., Ltd.
―
Seoulin Bioscience Co.,Ltd.
―
ilShinbiobase Co., Ltd.
―
Cell Bio Human Tech Co., Ltd
―
Cellromax Science Co., Ltd.
―